CompletedPhase 2NCT04401267

Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma

Studying Osteonecrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
St. Jude Children's Research Hospital
Principal Investigator
Seth E. Karol, MD
St. Jude Children's Research Hospital
Intervention
Intensive Antihypertensive Therapy(drug)
Enrollment
51 target
Eligibility
10 years · All sexes
Timeline
2020 – 2025

Study locations (2)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04401267 on ClinicalTrials.gov

Other trials for Osteonecrosis

Additional recruiting or active studies for the same condition.

See all trials for Osteonecrosis →

← Back to all trials